- Home
- ELVN vs ACDC Comparison
ELVN vs ACDC Comparison
Compare ELVN & ACDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELVN
- ACDC
- Stock Information
- Founded
- ELVN 2016
- ACDC 2014
- Country
- ELVN United States
- ACDC United States
- Employees
- ELVN N/A
- ACDC N/A
- Industry
- ELVN Biotechnology: Pharmaceutical Preparations
- ACDC Oilfield Services/Equipment
- Sector
- ELVN Health Care
- ACDC Energy
- Exchange
- ELVN Nasdaq
- ACDC Nasdaq
- Market Cap
- ELVN 1.2B
- ACDC 1.1B
- IPO Year
- ELVN 2020
- ACDC 2022
- Fundamental
- Price
- ELVN $21.64
- ACDC $7.79
- Analyst Decision
- ELVN Strong Buy
- ACDC Sell
- Analyst Count
- ELVN 5
- ACDC 4
- Target Price
- ELVN $41.20
- ACDC $6.50
- AVG Volume (30 Days)
- ELVN 608.9K
- ACDC 776.8K
- Earning Date
- ELVN 08-12-2025
- ACDC 08-07-2025
- Dividend Yield
- ELVN N/A
- ACDC N/A
- EPS Growth
- ELVN N/A
- ACDC N/A
- EPS
- ELVN N/A
- ACDC N/A
- Revenue
- ELVN N/A
- ACDC $2,209,700,000.00
- Revenue This Year
- ELVN N/A
- ACDC N/A
- Revenue Next Year
- ELVN N/A
- ACDC $0.38
- P/E Ratio
- ELVN N/A
- ACDC N/A
- Revenue Growth
- ELVN N/A
- ACDC N/A
- 52 Week Low
- ELVN $13.30
- ACDC $3.83
- 52 Week High
- ELVN $30.03
- ACDC $10.70
- Technical
- Relative Strength Index (RSI)
- ELVN 59.97
- ACDC 48.15
- Support Level
- ELVN $21.80
- ACDC $7.58
- Resistance Level
- ELVN $21.34
- ACDC $8.31
- Average True Range (ATR)
- ELVN 1.32
- ACDC 0.62
- MACD
- ELVN 0.18
- ACDC -0.09
- Stochastic Oscillator
- ELVN 85.90
- ACDC 47.76
About ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.
About ACDC ProFrac Holding Corp.
ProFrac Holding Corp is engaged in providing hydraulic fracturing, completion services, and other complementary products and services to upstream oil and gas companies engaged in the exploration and production of North American unconventional oil and natural gas resources. Its operations are focused in West Texas, East Texas/Louisiana, South Texas, Oklahoma, Uinta, and Appalachian. The company operates in three segments: Stimulation Services, Proppant Production, and Manufacturing. Stimulation services, which generate the majority of the revenue for the company operate a fleet of mobile hydraulic fracturing units and other auxiliary equipment that generates revenue by providing stimulation services.